Form 4: JPMorgan Chase Director Novakovic Acquires Shares Through Deferred Stock Grant

Sentiment:

SEC Form 4 Filing


Director Phebe Novakovic acquired 1,011.9262 shares of JPMorgan Chase & Co. common stock on January 21, 2025, through a deferred stock grant.

Summary

  • On January 21, 2025, Phebe Novakovic, a director of JPMorgan Chase & Co., acquired 1,011.9262 shares of common stock.
  • The acquisition was a result of a deferral of an annual stock grant, payable upon termination of service as a director.
  • The price per share was $261.8768.
  • Following the transaction, Novakovic directly owns 11,589.6679 shares of JPMorgan Chase & Co. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares signals confidence, but it's part of a pre-determined compensation plan.

Positives

  • The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The shares are payable upon termination of service as a director, indicating a long-term alignment of interests.

Industry Context

Director share acquisitions are common in the financial industry and are often viewed as a sign of confidence in the company's prospects.

Stakeholder Impact

  • The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates

DateDescription
01/21/2025Date of transaction: Phebe Novakovic acquired shares of JPM common stock.
01/23/2025Date of signature on the Form 4 filing.

Keywords

JPMorgan Chase & Co, Director, Novakovic, Stock Grant, Share Acquisition, Form 4, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.